Wu David C, Averbukh Leon D, Wu George Y
Department of Medicine, Division of Gastroenterology-Hepatology, University of Connecticut Health Center, Farmington, CT, USA.
J Clin Transl Hepatol. 2019 Jun 28;7(2):140-148. doi: 10.14218/JCTH.2018.00062. Epub 2019 May 13.
Peritoneal tuberculosis (PTB), although rarer than its pulmonary counterpart, is a serious health concern in regions of the world with high tuberculosis prevalence. Individuals with baseline immunocompromise condition, whether acquired or medically induced, are at greatest risk for experiencing PTB. While medical treatment of the condition is similar to that of the pulmonary disease, the generally immunocompromised state of those infected with PTB, along with a lack of highly sensitive and specific testing methods make early diagnosis difficult. This review discusses the risks factors, clinical features, diagnostic methods, and treatment options for PTB.
腹膜结核（PTB）虽然比肺结核少见，但在结核病高发地区却是一个严重的健康问题。患有基础免疫功能低下状况的个体，无论该状况是后天获得还是医源性的，患腹膜结核的风险最高。虽然该疾病的药物治疗与肺结核相似，但腹膜结核感染者通常处于免疫功能低下状态，加上缺乏高灵敏度和特异性的检测方法，使得早期诊断困难。本文综述了腹膜结核的危险因素、临床特征、诊断方法和治疗选择。
